These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9598228)

  • 21. Is the use of cardiopulmonary bypass for isolated coronary artery bypass an independent predictor of mortality and morbidity in patients with severe left ventricular dysfunction?
    Qiu ZB; Chen X; Xu M; Shi KH; Jiang YS; Xiao LQ
    Chin Med J (Engl); 2008 Dec; 121(23):2397-402. PubMed ID: 19102956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass grafting: a prospective, double-blinded, placebo-controlled, randomized study.
    Budeus M; Hennersdorf M; Perings S; Röhlen S; Schnitzler S; Felix O; Reimert K; Feindt P; Gams E; Lehmann N; Wieneke H; Sack S; Erbel R; Perings C
    Eur Heart J; 2006 Jul; 27(13):1584-91. PubMed ID: 16760210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of human class II furcation defects using connective tissue grafts, bioabsorbable membrane, and resorbable hydroxylapatite: a comparative study.
    Belal MH; Al-Noamany FA; El-Tonsy MM; El-Guindy HM; Ishikawa I
    J Int Acad Periodontol; 2005 Oct; 7(4):114-28. PubMed ID: 16245642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery.
    Echahidi N; Pibarot P; Després JP; Daigle JM; Mohty D; Voisine P; Baillot R; Mathieu P
    J Am Coll Cardiol; 2007 Aug; 50(9):843-51. PubMed ID: 17719470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a waiting period after clopidogrel treatment before performing coronary artery bypass grafting.
    Reichert MG; Robinson AH; Travis JA; Hammon JW; Kon ND; Kincaid EH
    Pharmacotherapy; 2008 Feb; 28(2):151-5. PubMed ID: 18225962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [How much can off-pump coronary artery bypass grafting be performed for complete revascularization using only in situ arterial conduits?].
    Niinami H; Takeuchi Y; Suda Y; Tabata M; Yamamoto M; Asano R; Ikeda M
    Kyobu Geka; 2003 Jul; 56(8 Suppl):661-6. PubMed ID: 12910947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does totally endoscopic access for off-pump cardiac surgery influence the incidence of postoperative atrial fibrillation in coronary artery bypass grafting? A preliminary report.
    Scherer M; Sirat AS; Dogan S; Aybek T; Moritz A; Wimmer-Greinecker G
    Cardiovasc Eng; 2006 Sep; 6(3):118-21. PubMed ID: 16967324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective randomized study to evaluate stress response during beating-heart and conventional coronary revascularization.
    Velissaris T; Tang AT; Murray M; Mehta RL; Wood PJ; Hett DA; Ohri SK
    Ann Thorac Surg; 2004 Aug; 78(2):506-12; discussion 506-12. PubMed ID: 15276508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Off-pump coronary artery bypass grafting with use of the octopus 2 stabilization system.
    Akpinar B; Güden M; Sagbas E; Sanisoglu I; Aytekin V; Bayindir O
    Heart Surg Forum; 2000; 3(4):282-6. PubMed ID: 11178288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wake-up test after carotid endarterectomy for combined carotid-coronary artery surgery: a case series.
    Türköz A; Türköz R; Gülcan O; Sener M; Kiziltan T; Calişkan E; Bozdoğan N; Arslan G
    J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):540-6. PubMed ID: 17678781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modified pericardial closure to protect internal mammary artery grafts in coronary artery bypass.
    Li JY; Chen YS; Wu SJ; Hu PY
    Thorac Cardiovasc Surg; 2002 Jun; 50(3):182-3. PubMed ID: 12077695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term survival of patients after coronary artery bypass graft surgery: comparison of the pre-stent and post-stent eras.
    Gao G; Wu Y; Grunkemeier GL; Furnary AP; Starr A
    Ann Thorac Surg; 2006 Sep; 82(3):806-10. PubMed ID: 16928488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case study of hospital closure and centralization of coronary revascularization procedures.
    Hemmelgarn BR; Ghali WA; Quan H
    CMAJ; 2001 May; 164(10):1431-5. PubMed ID: 11387915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early outcome of a randomized comparison of off-pump and on-pump multiple arterial coronary revascularization.
    Kobayashi J; Tashiro T; Ochi M; Yaku H; Watanabe G; Satoh T; Tagusari O; Nakajima H; Kitamura S;
    Circulation; 2005 Aug; 112(9 Suppl):I338-43. PubMed ID: 16159843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early and late outcome after off-pump coronary artery bypass graft surgery with coronary endarterectomy: a single-center 10-year experience.
    Vohra HA; Kanwar R; Khan T; Dimitri WR
    Ann Thorac Surg; 2006 May; 81(5):1691-6. PubMed ID: 16631657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival in patients with peripheral vascular disease after percutaneous coronary intervention and coronary artery bypass graft surgery.
    O'Rourke DJ; Quinton HB; Piper W; Hernandez F; Morton J; Hettleman B; Hearne M; Nugent W; O'Connor GT; Malenka DJ;
    Ann Thorac Surg; 2004 Aug; 78(2):466-70; discussion 470. PubMed ID: 15276497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of posterior pericardiotomy on the incidence of pericardial effusion and atrial fibrillation after coronary revascularization.
    Ekim H; Kutay V; Hazar A; Akbayrak H; Başel H; Tuncer M
    Med Sci Monit; 2006 Oct; 12(10):CR431-4. PubMed ID: 17006403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Coronary artery bypass grafting without cardiopulmonary bypass in 200 patients].
    Suma H; Isomura T; Horii T; Sato T
    J Cardiol; 2000 Aug; 36(2):85-90. PubMed ID: 10955252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, double-blind, placebo-controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft surgery: MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery Trial (MEND-CABG) II--study design and rationale.
    Mehta RH; Alexander JH; Emery R; Ellis SJ; Hasselblad V; Khalil A; Carrier M; Harrington RA; Tardif JC;
    Am Heart J; 2008 Apr; 155(4):600-8. PubMed ID: 18371465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic kidney disease as a risk factor for bleeding complications after coronary artery bypass surgery.
    Winkelmayer WC; Levin R; Avorn J
    Am J Kidney Dis; 2003 Jan; 41(1):84-9. PubMed ID: 12500224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.